Jan 24, 2018 12:00 pm UTC| Business
NEW YORK, Jan. 24, 2018 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
TRIO Announces Participation in the Avoca Diligent™ Prequalification Platform
Jan 24, 2018 12:00 pm UTC| Business
EDMONTON, Alberta, Jan. 24, 2018 -- Translational Research in Oncology (TRIO) is pleased to announce its participation in the Avoca Diligent™ Prequalification Platform. The purpose of this initiative is to increase...
Jan 24, 2018 12:00 pm UTC| Business
TREVOSE, Pa., Jan. 24, 2018 -- StoneMor Partners L.P. (NYSE:STON) (“StoneMor” or the “Partnership”) today announced that it plans to hold an investors' conference call and webcast to discuss its financial results for...
Jan 24, 2018 12:00 pm UTC| Business
WATERTOWN, Mass., Jan. 24, 2018 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye diseases, will report results for its second...
Jan 24, 2018 12:00 pm UTC| Business
SAN FRANCISCO, Jan. 24, 2018 -- Is there a skills gap in the U.S., or are employers merely failing to find and attract the right talent for their open roles? With job-hunting season in full swing again this January,...
Jan 24, 2018 12:00 pm UTC| Business
ALLEN, Texas, Jan. 24, 2018 -- Financial Gravity Companies, Inc., (OTCQB:FGCO), is pleased to announce that "The New Tax Law: How to Make it Work for You and Your Business" will be available in January 2018. The book,...
miRagen Therapeutics to Present New MRG-106 Phase 1 Clinical Trial Data at the T-Cell Lymphoma Forum
Jan 24, 2018 12:00 pm UTC| Business
BOULDER, Colo., Jan. 24, 2018 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today that new interim...